Tatsuhiko Naito1,2,3,4, Vialle Ricardo5, Kazuyoshi Ishigaki6, Yukinori Okada3,4,7, Knowles David2,8, Raj Towfique1 (1.Icahn School of Medicine at Mount Sinai, USA, 2.New York Genome Center, USA, 3.Department of Statistical Genetics, Osaka University, Japan, 4.Laboratory for Systems Genetics, RIKEN, Japan, 5.Rush University Medical Center, USA, 6.Laboratory for Human Immunogenetics, RIKEN, Japan, 7.Department of Genome Informatics, the University of Tokyo, Japan, 8.Columbia University, USA)
Session information
Oral Session
English
[O-37] Oral Session 37 [English]「Neuroscience」
Fri. May 31, 2024 8:00 AM - 9:30 AM Room14 (G610, Glass Building, 6F, TIF)
Chair(s): Shigeki Arawaka (Department of Neurology, Osaka Medical and Pharmaceutical University, Japan), Shinsuke Ishigaki (Molecular Neuroscience Research Center, Shiga University of Medical Science, Japan)
Tatsuro Mutoh1, Akihiro Ueda2, Yoshiki Niimi3, Hirohisa Watanabe1, Shota Sakai4 (1.Fujita Health University Hospital, Japan, 2.Fujita Healt University Okazaki Medical Center, Japan, 3.University of Tokyo Hospital, Unit for Early and Exploratory Clinical Development, Japan, 4.Faculty of Pharmacy, Hokkaido University, Japan)
Chikage Kijima1, Toshiki Inaba1, Kenichiro Hira1, Nobukazu Miyamoto1, Kazuo Yamashiro2, Takao Urabe2, Yuji Ueno3, Nobutaka Hattori1,4 (1.Department of Neurology, Juntendo University School of Medicine, Japan, 2.Department of Neurology, Juntendo University Urayasu Hospital, Japan, 3.Department of Neurology, University of Yamanashi, Japan, 4.Neurodegenerative Disorders Collaborative Laboratory, RIKEN Center for Brain Science, Japan)
Fumito Endo1,6, Soto Joselyn1, Gradinaru Viviana4, Wohlschlegel James3, Riki Kawaguchi5, Khakh Baljit1,2 (1.Department of Physiology, David Geffen School of Medicine, University of California, Los Angeles, USA, 2.Department of Neurobiology, David Geffen School of Medicine, University of California, Los Angeles, USA, 3.Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, USA, 4.Division of Biology and Biological Engineering, California Institute of Technology, USA, 5.Center for Neurobehavioral Genetics, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, USA, 6.Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, Japan)
[O-37-5] Pathologic changes in NIID are linked to aberrant FUS interaction under hyperosmotic stress
Jianwen Deng1, Hui Wang1, Yilei Zheng1,2, Daojun Hong2, Yun Yuan1, Zhaoxia Wang1 (1.Peking university first hospital, China, 2.The First Affiliated Hospital of Nanchang University, China)
Dharmendra K. Khatri, Anika Sood (National Institute of Pharmaceutical Education and Research Hyderabad, India)